Literature DB >> 14757930

Spinal cord regeneration: moving tentatively towards new perspectives.

D G Jones1, E R Anderson, K A Galvin.   

Abstract

The failure of the adult human spinal cord to regenerate following injury is not absolute, but appears to be amenable to therapeutic manipulation. Recent work has shown that the provision of a growth permissive environment by the neutralization of inhibitory influences, or the grafting of fetal tissue, peripheral nerve, Schwann cells, or olfactory ensheathing cells can enhance regeneration in animal models of spinal cord injury. Stem cells are gaining ever-increasing favour as a treatment option for spinal cord injury. The potential of neural stem cells, embryonic stem cells, and bone marrow stromal cells is discussed. Additional treatment options such as pharmacological interventions, functional electrical stimulation and physiotherapy approaches are also explored. Basic science insights are used as a foundation for a discussion of a variety of clinical perspectives including repair of the chronically injured spinal cord, animal models of human spinal cord injuries and clinical trials. A more holistic approach towards spinal cord injury is suggested, one where a hierarchy of needs is recognised and quality of life is paramount. Finally, this review cautions against overly grandiose claims of an imminent miracle cure for human spinal cord injury.

Entities:  

Mesh:

Year:  2003        PMID: 14757930

Source DB:  PubMed          Journal:  NeuroRehabilitation        ISSN: 1053-8135            Impact factor:   2.138


  10 in total

Review 1.  Cellular transplantation strategies for spinal cord injury and translational neurobiology.

Authors:  Paul J Reier
Journal:  NeuroRx       Date:  2004-10

2.  Biohybrid Carbon Nanotube/Agarose Fibers for Neural Tissue Engineering.

Authors:  Dan Y Lewitus; John Landers; Jonathan Branch; Karen L Smith; Gerardo Callegari; Joachim Kohn; Alexander V Neimark
Journal:  Adv Funct Mater       Date:  2011-07-22       Impact factor: 18.808

3.  Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injury.

Authors:  Susanna S Park; Sergio Caballero; Gerhard Bauer; Bradley Shibata; Alan Roth; Paul G Fitzgerald; Krisztina I Forward; Ping Zhou; Jeannine McGee; David G Telander; Maria B Grant; Jan A Nolta
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-23       Impact factor: 4.799

Review 4.  Therapeutical Strategies for Spinal Cord Injury and a Promising Autologous Astrocyte-Based Therapy Using Efficient Reprogramming Techniques.

Authors:  Hao Yang; Cui-Cui Liu; Chun-Yu Wang; Qian Zhang; Jiang An; Lingling Zhang; Ding-Jun Hao
Journal:  Mol Neurobiol       Date:  2015-04-12       Impact factor: 5.590

5.  Tailless-like (TLX) protein promotes neuronal differentiation of dermal multipotent stem cells and benefits spinal cord injury in rats.

Authors:  Tao Wang; Xiaobao Ren; Jianqiong Xiong; Lei Zhang; Jifu Qu; Wenyue Xu
Journal:  Cell Mol Neurobiol       Date:  2011-01-22       Impact factor: 5.046

Review 6.  Stem cells in amniotic fluid as new tools to study human genetic diseases.

Authors:  Nicol Siegel; Margit Rosner; Michaela Hanneder; Alessandro Valli; Markus Hengstschläger
Journal:  Stem Cell Rev       Date:  2007-12       Impact factor: 5.739

7.  Circulating mononuclear progenitor cells: differential roles for subpopulations in repair of retinal vascular injury.

Authors:  Sergio Caballero; Sugata Hazra; Ashay Bhatwadekar; Sergio Li Calzi; Linda J Paradiso; Leonard P Miller; Lung-Ji Chang; Timothy S Kern; Maria B Grant
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-26       Impact factor: 4.799

8.  Improvement of Contused Spinal Cord in Rats by Cholinergic-like Neuron Therapy.

Authors:  Majid Naghdi; Taki Tiraihi; Seyed Alireza Mesbah-Namin; Jalil Arabkharadmand; Hadi Kazemi; Taher Taheri
Journal:  Iran Red Crescent Med J       Date:  2013-02-05       Impact factor: 0.611

9.  Reduction in antioxidant enzyme expression and sustained inflammation enhance tissue damage in the subacute phase of spinal cord contusive injury.

Authors:  Chih-Yen Wang; Jen-Kun Chen; Yi-Ting Wu; May-Jywan Tsai; Song-Kun Shyue; Chung-Shi Yang; Shun-Fen Tzeng
Journal:  J Biomed Sci       Date:  2011-02-07       Impact factor: 8.410

10.  Repetitive Treatment with Diluted Bee Venom Attenuates the Induction of Below-Level Neuropathic Pain Behaviors in a Rat Spinal Cord Injury Model.

Authors:  Suk-Yun Kang; Dae-Hyun Roh; Jung-Wan Choi; Yeonhee Ryu; Jang-Hern Lee
Journal:  Toxins (Basel)       Date:  2015-07-10       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.